Clinical Trial Update: Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer

View source ↗

Summary

Pilot study update evaluating patient adherence to lapatinib (TYKERB/TYVERB) plus capecitabine in metastatic breast cancer; the trial sponsored by GlaxoSmithKli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TYKERB/TYVERB (lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer | Status: COMPLETED